Today

Agents

Chat

Arena

Discover

More

App

Lunai Bioworks Signs Agreement With Brainstorm Therapeutics - LNAI News | Rallies

Lunai Bioworks Signs Agreement With Brainstorm Therapeutics

LNAI•2026-08-04

Collaboration agreement with Brainstorm Therapeutics

Lunai Bioworks Inc. (NASDAQ: LNAI) said it signed a definitive collaboration agreement with Brainstorm Therapeutics.

Initial Parkinson's disease data readout is targeted for the first half of 2027.

Related News

Lattice Semiconductor posts corporate overview presentation on low-power FPGA, secure firmware strategy

LSCC•2026-08-04

Ternium 2Q26 adjusted EBITDA rises 50% to $717 million; net sales increase to $4.34 billion

TX•2026-08-04

Decoy Therapeutics announces special shareholder meeting via webcast

DCOY•2026-08-04

EOG Resources forecasts FY 2026 capital spending at USD 6.3 billion-6.7 billion

EOG•2026-08-04

Paramount Skydance amends 8-K to correct pro forma financial statement table in Exhibit 99.3

PSKY•2026-08-04